English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Biomarin Pharmaceuticals
Carol Ostrow
| Dec 28, 2017
BioMarin presents revised clinical data for hemophilia A treatment
Ruth de Jauregui
| Jun 8, 2017
BioMarin's Brineura gets European approval for treating CLN2 brain disease in children
Chandra Lye
| May 4, 2017
Drug offers hope for children with rare brain disease
Caitlin Nordahl
| Apr 24, 2017
BioMarin, Par reach settlement on Kuvan
Jeff Gantt
| Dec 18, 2016
BioMarin Pharmaceutical initiates phase 3 vosoritide trial
Amanda Rupp
| May 11, 2016
BioMarin releases EMA grants for Batten disease treatment
Trending
+
Community
Patient Daily
| Mar 14, 2025
Doctor on weather-related pressure headaches: This could happen 'if you have an underlying chronic sinus disease'
+
Pharmaceuticals
Patient Daily
| Mar 20, 2025
Patients Come First spokesperson on drug pricing reform: 'Vulnerable patients are depending on them to fix 340B'
C.D. Marsden
| Mar 14, 2025
Solidarity Health to Musk, RFK, Jr: ‘Enforce the CMS Hospital Price Transparency Rule’
+
Pharmaceuticals
Patient Daily
| Mar 14, 2025
Research links new CDKL gene variants to neurodevelopmental disorders
